Clinical Trial Update: Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiotherapy in combination with a checkpoint inhibitor for metastatic renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Checkpoint inhibitor (unspecified)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Metastatic Renal Cell Carcinoma ( mRCC), OligoProgressive Metastatic Disease | Phase 2 | Status: RECRUITING